...
首页> 外文期刊>European journal of heart failure: journal of the Working Group on Heart Failure of the European Society of Cardiology >Cardiac resynchronization therapy for the causal treatment of heart failure with preserved ejection fraction: insight from a pressure-volume loop analysis.
【24h】

Cardiac resynchronization therapy for the causal treatment of heart failure with preserved ejection fraction: insight from a pressure-volume loop analysis.

机译:保留射血分数的心力衰竭因果治疗的心脏再同步疗法:从压力-体积环分析中获得的见识。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

This case describes a middle-aged patient with normal ejection fraction (64%) and significant dyspnoea which could not be explained by results from routine examinations. A pressure-volume loop analysis revealed severe left ventricular (LV) dyssynchrony to be the underlying mechanism of heart failure. The patient underwent implantation of a biventricular pacemaker. Cardiac resynchronization therapy (CRT) was associated with an immediate reduction in LV dyssynchrony from 32 to 13%, decrease in LV end-diastolic pressure from 19 to 8 mmHg, and increased exercise tolerance during follow-up. Thus, CRT may be considered a causal therapy in selected patients with heart failure and preserved ejection fraction.
机译:该病例描述了一名射血分数正常(64%)且呼吸困难严重的中年患者,常规检查结果无法解释。压力-容量环分析显示,严重的左心室(LV)不同步是心力衰竭的潜在机制。该患者接受了双心室起搏器的植入。心脏再同步治疗(CRT)可将左室不同步立即从32%降低到13%,左室舒张末期压力从19 mmHg降低到随访期间的运动耐量。因此,在某些心力衰竭且射血分数保留的患者中,CRT可被视为因果疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号